On The Way to Innovation: Pharmaceutical/Analytical Technology, Regulation and Knowledge Management

Preliminary Program Agenda

Updated February 26, 2015

Tuesday 4 August

Registration & Continental Breakfast

Welcome & Opening Remarks

Mike Lee

Mike S. Lee
Milestone Development Services

Rafael Barrientos

Format, Objectives, Opening Remarks
Rafael Barrientos
Eurofarma Laboratórios S.A.

Plenary Lecture

Nathan Yates

A Global Overview on Biomarkers, Large Molecules and Proteomics
Nathan A. Yates Bio
University of Pittsburgh

Symposium Session

Fixed Drug Combination (FDC): BA/BE, Pharmaceutical Equivalence and Regulatory Updates
Chair: Mauricio Magalhães, EMS

Sponsored Lunch & Roundtable Event

Symposium Session

Clinical Assays in Brazil: Regulatory Updates and Challenges
Chair: Carlos Kiffer - GC2

Pharmaceutical Industry Perspective
Debora Garcia Rodrigues, Cristália

Class Association Perspective
Vitor Harada, Quintiles

CRO Perspective
José Emílio S. Neto, Icon Clinical Research

Symposium Session

New Drug Release and Process Technologies: An Overview
Chair: Gabriel Araújo, University of São Paulo

Wednesday 5 August

Registration & Continental Breakfast

Symposium Session

Biossimilars: Where Are We and Where Are We Going?
Chair: Vanda Magalhaes, Eurofarma

Sponsored Lunch & Roundtable Event

Symposium Session

Drug Discovery: Are We Prepared for That?
Chair: Gabriela Barreiro, Eurofarma

Symposium Session

Personalize Medicine with Better Diagnoses, Better Treatment Through Innovative Analytical Methods
Co-Chairs: Daniel Lebre, CEMSA and Dulce Casarini, UNIFESP

Wrap Up & Adjourn
Rafael Barrientos, Eurofarma Laboratórios S.A and Mike Lee, Milestone Development Services